News | February 06, 2024
Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022
The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
The business and product range of Ipca and that of Unichem complements each others business and product range
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)